ABSCI CORP Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- ABSCI CORP share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-06-30 was 1.65M shares, a 2426.36% increase year-over-year.
- ABSCI CORP share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-03-31 was 606.39K shares, a 13.46% decline year-over-year.
- ABSCI CORP share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-12-31 was 431.56K shares, a 72.42% increase year-over-year.
- ABSCI CORP share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-09-30 was 98.42K shares, a 82.89% decline year-over-year.
- ABSCI CORP share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2025 was 1.30M shares, a 29.48% decline from fiscal 2024.
- ABSCI CORP share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 1.84M shares, a 230.33% increase from fiscal 2023.
- ABSCI CORP share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 556.43K shares, a 3.60% increase from fiscal 2022.
- ABSCI CORP share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2022 was 537.08K shares, a 250.08% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2026-06-30 | 1.65M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | 2.79M shares derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | 606.39K shares 10-Q · filed 2026-05-07 | 1.20M shares derived: sum of 4 quarters · filed 2026-05-07 |
| 2025-12-31 | 431.56K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | 1.30M shares 10-K · filed 2026-03-24 |
| 2025-09-30 | 98.42K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | 1.11M shares derived: sum of 4 quarters · filed 2025-11-12 |
| 2025-06-30 | 65.46K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | 1.59M shares derived: sum of 4 quarters · filed 2025-08-12 |
| 2025-03-31 | 700.68K shares 10-Q · filed 2025-05-13 | 2.00M shares derived: sum of 4 quarters · filed 2025-05-13 |
| 2024-12-31 | 250.30K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | 1.84M shares 10-K · filed 2025-03-18 |
| 2024-09-30 | 575.30K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | 1.72M shares derived: sum of 4 quarters · filed 2024-11-12 |
| 2024-06-30 | 469.69K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | 1.41M shares derived: sum of 4 quarters · filed 2024-08-14 |
| 2024-03-31 | 542.74K shares 10-Q · filed 2024-05-14 | 1.04M shares derived: sum of 4 quarters · filed 2024-05-14 |
| 2023-12-31 | 135.80K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | 556.43K shares 10-K · filed 2024-03-21 |
| 2023-09-30 | 258.64K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | 484.00K shares derived: sum of 4 quarters · filed 2023-11-14 |
| 2023-06-30 | 107.21K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | 316.49K shares derived: sum of 4 quarters · filed 2023-08-14 |
| 2023-03-31 | 54.77K shares 10-Q · filed 2023-05-15 | 404.70K shares derived: sum of 4 quarters · filed 2023-05-15 |
| 2022-12-31 | 63.37K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | 537.08K shares 10-K · filed 2023-03-30 |
| 2022-09-30 | 91.14K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | 564.51K shares derived: sum of 4 quarters · filed 2022-11-09 |
| 2022-06-30 | 195.42K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | 473.37K shares derived: sum of 4 quarters · filed 2022-08-11 |
| 2022-03-31 | 187.15K shares 10-Q · filed 2022-05-11 | |
| 2021-12-31 | 90.80K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-22 | 153.42K shares 10-K · filed 2022-03-22 |
| 2021-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |